Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix H. LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Shares Traded Last Trade
  +11.00p +11.00% 111.00p 401,576 16:27:19
Bid Price Offer Price High Price Low Price Open Price
109.00p 113.00p 111.00p 98.50p 100.50p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.19 1.69 2.43 45.7 93.6

Optibiotix H. (OPTI) Latest News

More Optibiotix H. News
Optibiotix H. Takeover Rumours

Optibiotix H. (OPTI) Share Charts

1 Year Optibiotix H. Chart

1 Year Optibiotix H. Chart

1 Month Optibiotix H. Chart

1 Month Optibiotix H. Chart

Intraday Optibiotix H. Chart

Intraday Optibiotix H. Chart

Optibiotix H. (OPTI) Discussions and Chat

Optibiotix H. Forums and Chat

Date Time Title Posts
18/8/201818:19OptiBiotix - Better Science, Better Health. Better buy some!40,229
17/8/201816:32OptiBiotix - The uncensored thread 2,533
16/8/201809:38more sugar vicar?3 Bags full Yes pls!gla27
01/8/201809:21Free Shares1

Add a New Thread

Optibiotix H. (OPTI) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Optibiotix H. trades in real-time

Optibiotix H. (OPTI) Top Chat Posts

Optibiotix H. Daily Update: Optibiotix H. is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix H. was 100p.
Optibiotix H. has a 4 week average price of 86.50p and a 12 week average price of 62p.
The 1 year high share price is 133p while the 1 year low share price is currently 54p.
There are currently 84,366,475 shares in issue and the average daily traded volume is 550,002 shares. The market capitalisation of Optibiotix H. is £93,646,787.25.
siennadelekat21: Dire,I'm afraid Monkey is a premium subscriber and as a result advfn will do nothing about him. Before OPTI, he infested the CPX board for ages until the share price actually did well. Hopefully when the OPTI share price moves up further he will eventually move on and infest another board (fingers crossed).Sienna
michaelmouse: Eric - How many multi-million pound companies can you name that have a handful of employees who work from their bedrooms? Despite you and other shareholders insisting that Opti would be self funding and already be generating cash they have done neither. I said they'd have to raise funds and they did. They'll have to do it again. PLC costs have been rising year on year and I expect them to accelerate. Until we get some decent figures how can you or anyone else judge their business model? Utter nonsense. Why would SOH need to guess revenues for 2018 when they're already 8 months in to 2018? I'm more worried that he doesn't want to release them. He certainly knows revenues in the first 6 months since he'll have to publish them by the end of August. As for the $billion dollar companies lining up for Opti technology, I've heard it a million times on "story" stocks e.g. TERN most recently. They need those deals to justify the current market cap. "At at 15p I think I can suggest I have been more right than wrong." The share price has gone up but revenues haven't. Watch the figures and not the share price. TERN down 40% in a day and I can see further heartache ahead because the figures just didn't match the share price "Once clinical studies are proven successful he’ll be watching the share price rise saying the same thing." If they aren't successful or lacklustre then what? See IMM.
michaelmouse: AVN was certainly a mistake. It was a "story" stock. Just like Opti. TRAK has been wonderful for me, and has made true commercial progress. It produces revenues and profits. Plenty to come there, although talking of share price spikes then it's worth studying to see how it's the numbers that dictate the share price over the long term. Compare Opti financials to Trak. Opti is a disaster waiting to happen. INTQ. Not me. Never interested. STL, 7DIG and AEO all produce more revenue and have superior balance sheets to Opti, but all currently a fraction of Opti's market cap. It should ring alarm bells for Opti holders!!! Very loud alarm bells!!!! I won't mention all the multi-baggers, although CALL was the most recent success I wrote about on my blog:- hTTp:// Enjoy! You're needed on the other Opti thread to keep the pyramid scheme alive, but remember to bail before it's too late ;-) Anyway, the reality of the interims shortly. End of August. Bye for now.
michaelmouse: 16 March 2016 (start of thread) - Opti share price was 74p. Today it's up 59%. That's about 22% compounded per annum. Pretty good but not spectacular yet!! I wouldn't touch either Opti or Sbtx with a barge pole, but good luck anyway. Overvalued shares getting even more overvalued and a great example of irrational exuberance by the numpties! Both have ridiculous multi-million market caps with next to zero revenues reported. In the end it's always the figures that dictate the share price. See CPT today. I'll watch and wait. Let me know if you take profits. It might be the sensible option at this stage before the bubble bursts. If I was SOH I'd cash in the sbtx shares (if he can sell all his 42%) before the bear market really revs up because (whilst it's difficult to detect) I think this is the start. ;)
parob: I personally don't think SBTX is priced in to the OPTI share price - LPL-DL, SlimBiome, LPGOS, and Sweetbiotix combined are easily worth £100M plus imo. In fact I would have thought announcing a divi of 12p would give the shares a boost! Let's see what comes of these multi-billion turnover company Sweetbiotix deals. If any "cross the product launch line" then a valuation of £100m NOW for Sweetbiotix isn't out of the question. Corporate's will pay huge premiums to block their competitors from market penetration.
michaelmouse: slarty - This isn't the trak thread, but trak's share price performance has been poor over those two years but terrific over a longer period, not dissimilar to Opti's share price performance (as already mentioned), although of course trak's share price reached far greater heights at one stage. However, (currently) trakm8 is at worst fairly priced (and possibly hugely undervalued longer term) with reported revenues in excess of £30m in it's last report, good positive cash flow and profits. Remind me again about Opti's reported figures and projections for the current year? Next to zero revenues, cash burning and losing money, and yet Opti boasts a higher market cap. Interesting? That leads me on to your question. "Btw Imm and N4p are pharma and we know pharma can be brutal. Whats Opti?" Pharma can be brutal so why did so many Opti holders buy into those two story stocks then? Opti is a low revenue generating, cash guzzling, loss making company that is venturing into pharma. That's what Opti is. Hope that answers your question?
pj 1: FWIW I'm happy for them to hold off on the Skin distribution as I think there will huge appreciation there over the years, as long as there is also appreciation in the OPTI share price.
nimrod22: OPTI share price loves to cycle up and down like a yoyo, its a pity that it never actually takes off despite all the news that it generates. Now lower than what it was two years ago, gofigure.
judijudi: Opti share price dropping blamed on Trump That’s the best yet :)
michaelmouse: Let's start with this shall we:- "We know your true game going on your persistence to troll Opti via multiple usernames over the years." I am a "free" member of ADVFN and wouldn't dream of parting with any cash to join for so very many reasons. If you wish, you have permission to contact ADVFN and check that I have only ever used the michaelmouse username. I will presume that you, Eric and the others give me permission to do the same? Only the saddest of tw*ts needs more than one username. Does that make it clear? Secondly, are you really naïve enough to believe that all their partners are going to spend multi-millions on marketing Opti's "magic" ingredient? For instance, think about the online store. Unless they do substantial marketing then nobody will know it even exists. Don't rely on their partners to stump up for this. Besides it'll take years to try and educate people about how their "magic" formula differs from the thousands already out there. Thirdly, you no nothing about large holdings in micro-cap companies if you think that they can cash in their SBTX holding anytime after the lock-in period has ended. They couldn't sell 5% of SBTX at anything near the current share price never mind 42%. As I've said many times already, they're locked-in well beyond the official period. If the share price of SBTX had taken off, as I am sure they'd hoped, when it floated then they may have indeed found it easier to sell some and raise some cash. However, as I predicted, the share price fell back below the placing price, and the illiquidity of the shares will prevent them selling enough to raise any cash in the foreseeable future. Hence, (imo) they have no choice but to raise cash through the normal channels. At the sbtx flotation I said it was irresponsible of SOH to call SBTX "a rising asset", it can be "a falling asset" as well and highly illiquid which means the shares can't be sold in a hurry. Finally, you are naïve to think that the public at large will quickly see the benefits of Opti's technology. If I go into any supermarket then there are thousands of different products claiming all sorts of wonderful things albeit in a very clever way. It'll take at least a decade for a new comer to make an impression even if it does at all. In the meantime, the competition catches up or an enhanced or improved technology supercedes it. The market is saturated with similar types of product. If you're thinking that the partners are already established with their products then it's true to an extent, but the products which include Opti's ingredients will be new to the customer and if they don't sell well then they'll just drop Opti as a supplier and discontinue the product line. As for full year 2018 results, I'll await them with much interest because therein lies a huge problem, the company just won't give any guidance. It must have some idea now surely we're already 4/5months into their 2018 year? After all, whatever investors own views are, ultimately it's the figures that will drive the share price up or down. I personally can't envisage them getting to cash flow break even anytime soon, and hence I see a fund raising is inevitable at a discount to today's share price. As ever, these are just my opinions and thoughts. If others differ then that's their prerogative.
Optibiotix H. share price data is direct from the London Stock Exchange
add chat code
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20180818 20:02:47